Rheumatology and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 63.8% | 0.991 | Q2 | 83.6% |
| 2024 | 2.9 | Q2 | 67.2% | 1.099 | Q2 | 86.5% |
| 2023 | 2.9 | Q2 | 66.7% | 1.071 | Q2 | 87.2% |
| 2022 | 3.8 | Q3 | 65.5% | 1.242 | Q1 | 90.5% |
| 2021 | 4.1 | Q3 | 67.3% | 1.076 | Q2 | 88.0% |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2198-6584
ISSN
2198-6576
region
Western Europe
coverage
2014-2026